Skip to main content
Caplight Logo









4B Technologies

4B Technologies

Private
BeijingHealthcare & Life Scienceshttps://4btechnologies.com/

Last Round

Series B

Dec 12, 2022

Total Funding Raised

$39M

Company Overview

4B Technologies is a biopharmaceutical company that is engaged in the research, development, and commercialization of transformative medicines targeting neurological disorders and CNS-related conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaldrug discoverycentral nervous systemCNSclinical trialsbiotechneurodegenerative diseasedrug deliverymonoclonal antibodyAI drug discoverybiotech startuptherapeutic pipelinebiomarkerpharma licensingdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

4B Technologies Comparables

Compare 4B Technologies with similar companies based on industry and business-model similarity.

4B Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Athira Pharma
71%
Annovis Bio, Inc.
70%
Alector
69%

4B Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 12, 2022
Series A ExtensionFeb 10, 2021
Series A ExtensionJun 20, 2020
Series AJan 1, 2020
AngelJun 1, 2019

4B Technologies Investors

Notable investors and investment history

4B Technologies investors
InvestorRounds
Fengchuan CapitalSeries A Extension
Daoyuan CapitalSeries B
Foothill VenturesSeries B, Series A Extension, Series A
Shenzhen Dachen Caizhi Venture Capital ManagementSeries A Extension, Series B
芳晟股权投资基金Series B
Sinovation VenturesSeries A Extension, Angel
华创资本Series A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2020

    Gaorong Capital participated in the round.

4B Technologies Filings

Explore SEC and related filing metadata, where available.

4B Technologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 4B Technologies's valuation, stock price, and market status.

Is 4B Technologies a public or private company?

4B Technologies is a private company.

What is the current stock price of 4B Technologies?

4B Technologies is a private company with no public stock price. No recent secondary market data is available.

How much is 4B Technologies worth (valuation)?

Valuation information for 4B Technologies is not publicly available.

Can I buy 4B Technologies stock?

4B Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 4B Technologies's last funding round?

4B Technologies's most recent funding round was Early Funding on December 12, 2022.

Who are the main investors in 4B Technologies?

Key investors in 4B Technologies include Shenzhen Dachen Caizhi Venture Capital Management, Gaorong Capital.

Will 4B Technologies IPO soon?

No public IPO plans have been announced for 4B Technologies.

How can I track 4B Technologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 4B Technologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Employee Range11
Year Founded2018
Last FundingDec 12, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?